1. Home
  2. PDM vs PCRX Comparison

PDM vs PCRX Comparison

Compare PDM & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Piedmont Office Realty Trust Inc.

PDM

Piedmont Office Realty Trust Inc.

HOLD

Current Price

$8.23

Market Cap

1.0B

Sector

Real Estate

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$25.01

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDM
PCRX
Founded
1997
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Building operators
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
1997
2010

Fundamental Metrics

Financial Performance
Metric
PDM
PCRX
Price
$8.23
$25.01
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$9.00
$30.25
AVG Volume (30 Days)
1.2M
458.9K
Earning Date
04-30-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
107.44
EPS
N/A
0.07
Revenue
$564,994,000.00
$541,533,000.00
Revenue This Year
$4.21
$6.78
Revenue Next Year
$1.29
$8.54
P/E Ratio
N/A
$346.71
Revenue Growth
N/A
26.04
52 Week Low
$6.32
$18.80
52 Week High
$9.19
$27.64

Technical Indicators

Market Signals
Indicator
PDM
PCRX
Relative Strength Index (RSI) 68.47 57.09
Support Level $8.03 $20.27
Resistance Level $8.89 $25.50
Average True Range (ATR) 0.25 1.15
MACD 0.05 -0.00
Stochastic Oscillator 81.51 52.36

Price Performance

Historical Comparison
PDM
PCRX

About PDM Piedmont Office Realty Trust Inc.

Piedmont Realty Trust Inc is a fully integrated, self-managed real estate investment company focused on delivering an exceptional office environment. As an owner, manager, developer and operator of 16 MM SF of Class A properties across U.S. Sunbelt markets, Piedmont Realty Trust is known for its hospitality-driven approach and commitment to transforming buildings into Piedmont PLACEs that enhance each client's workplace experience.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: